The Experts below are selected from a list of 285 Experts worldwide ranked by ideXlab platform
Bruno Quesnel - One of the best experts on this subject based on the ideXlab platform.
-
Successful treatment of imatinib-resistant Acute Megakaryoblastic Leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation.
Leukemia, 2007Co-Authors: Selim Corm, Aline Renneville, E Rad-quesnel, Nathalie Grardel, Claude Preudhomme, Bruno QuesnelAbstract:Successful treatment of imatinib-resistant Acute Megakaryoblastic Leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation
-
successful treatment of imatinib resistant Acute Megakaryoblastic Leukemia with e6a2 bcr abl use of dasatinib and reduced conditioning stem cell transplantation
Leukemia, 2007Co-Authors: Selim Corm, Aline Renneville, Nathalie Grardel, Claude Preudhomme, Bruno Quesnel, E RadquesnelAbstract:Successful treatment of imatinib-resistant Acute Megakaryoblastic Leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation
Selim Corm - One of the best experts on this subject based on the ideXlab platform.
-
Successful treatment of imatinib-resistant Acute Megakaryoblastic Leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation.
Leukemia, 2007Co-Authors: Selim Corm, Aline Renneville, E Rad-quesnel, Nathalie Grardel, Claude Preudhomme, Bruno QuesnelAbstract:Successful treatment of imatinib-resistant Acute Megakaryoblastic Leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation
-
successful treatment of imatinib resistant Acute Megakaryoblastic Leukemia with e6a2 bcr abl use of dasatinib and reduced conditioning stem cell transplantation
Leukemia, 2007Co-Authors: Selim Corm, Aline Renneville, Nathalie Grardel, Claude Preudhomme, Bruno Quesnel, E RadquesnelAbstract:Successful treatment of imatinib-resistant Acute Megakaryoblastic Leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation
Claude Preudhomme - One of the best experts on this subject based on the ideXlab platform.
-
Successful treatment of imatinib-resistant Acute Megakaryoblastic Leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation.
Leukemia, 2007Co-Authors: Selim Corm, Aline Renneville, E Rad-quesnel, Nathalie Grardel, Claude Preudhomme, Bruno QuesnelAbstract:Successful treatment of imatinib-resistant Acute Megakaryoblastic Leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation
-
successful treatment of imatinib resistant Acute Megakaryoblastic Leukemia with e6a2 bcr abl use of dasatinib and reduced conditioning stem cell transplantation
Leukemia, 2007Co-Authors: Selim Corm, Aline Renneville, Nathalie Grardel, Claude Preudhomme, Bruno Quesnel, E RadquesnelAbstract:Successful treatment of imatinib-resistant Acute Megakaryoblastic Leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation
Aline Renneville - One of the best experts on this subject based on the ideXlab platform.
-
Successful treatment of imatinib-resistant Acute Megakaryoblastic Leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation.
Leukemia, 2007Co-Authors: Selim Corm, Aline Renneville, E Rad-quesnel, Nathalie Grardel, Claude Preudhomme, Bruno QuesnelAbstract:Successful treatment of imatinib-resistant Acute Megakaryoblastic Leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation
-
successful treatment of imatinib resistant Acute Megakaryoblastic Leukemia with e6a2 bcr abl use of dasatinib and reduced conditioning stem cell transplantation
Leukemia, 2007Co-Authors: Selim Corm, Aline Renneville, Nathalie Grardel, Claude Preudhomme, Bruno Quesnel, E RadquesnelAbstract:Successful treatment of imatinib-resistant Acute Megakaryoblastic Leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation
Falko Fend - One of the best experts on this subject based on the ideXlab platform.
-
transient abnormal myelopoiesis Acute Megakaryoblastic Leukemia diagnosed in the placenta of a stillborn down syndrome fetus with targeted next generation sequencing
Leukemia, 2015Co-Authors: Birgit Federmann, A Fasan, K O Kagan, Sebastian P. Haen, Falko FendAbstract:Transient abnormal myelopoiesis/Acute Megakaryoblastic Leukemia diagnosed in the placenta of a stillborn Down syndrome fetus with targeted next-generation sequencing
-
Transient abnormal myelopoiesis/Acute Megakaryoblastic Leukemia diagnosed in the placenta of a stillborn Down syndrome fetus with targeted next-generation sequencing
Leukemia, 2014Co-Authors: Birgit Federmann, A Fasan, K O Kagan, Sebastian P. Haen, Falko FendAbstract:Transient abnormal myelopoiesis/Acute Megakaryoblastic Leukemia diagnosed in the placenta of a stillborn Down syndrome fetus with targeted next-generation sequencing
